Benzinga | Nov 11, 2020 04:05PM EST

PDS Biotechnology Q3 EPS $(0.23) Misses $(0.20) Estimate

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.20) by 15 percent. This is a 79.09 percent increase over losses of $(1.10) per share from the same period last year.